| Name | SLC44A3 antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have underscored the importance of enhancer RNAs (eRNAs) in the regulation of gene expression within various cancers, including esophageal cancer. In a comprehensive analysis, SLC44A3‐AS1 has emerged as one of the critical eRNA candidates whose altered expression may influence oncogenic pathways and tumor behavior. Its activity appears to be associated with the modulation of transcriptional programs that drive tumor progression and may serve as an indicator of disease status."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, SLC44A3‐AS1 is proposed to participate in the remodeling of chromatin landscapes, thereby facilitating the interaction between distal enhancers and promoters. This interaction might regulate the downstream genes involved in cell proliferation and apoptosis, suggesting that aberrations in SLC44A3‐AS1 expression have a direct impact on the molecular circuitry of esophageal cancer cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these findings indicate that SLC44A3‐AS1 plays a multifaceted role as an enhancer RNA in esophageal cancer by modulating key transcriptional networks and chromatin dynamics. Its potential utility as a prognostic biomarker or therapeutic target highlights the need for further investigation into the molecular mechanisms underlying its function in oncogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kai Kang, Jingyi Wu, Yajun Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Coll Physicians Surg Pak (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.29271/jcpsp.2023.09.964"}], "href": "https://doi.org/10.29271/jcpsp.2023.09.964"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37691355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37691355"}]}]}]}
|
| NCBI Gene ID | 101928079 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC44A3-AS1 has 0 functional associations with biological entities spanning 0 categories () extracted from 0 datasets.
Click the + buttons to view associations for SLC44A3-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary |
|---|